ArticleJournal of global oncology2017
Outcomes in Lung Cancer: 9-Year Experience From a Tertiary Cancer Center in India.
Article in Journal of global oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Outcomes and Prognostic Factors of Extensive Stage Small Cell Lung Cancer: A Retrospective Study.South Asian journal of cancer · 2025Article
- Clinical spectrum of lung cancer across hospitals under the National Cancer Registry Programme in India: Challenges and opportunities.Lung India : official organ of Indian Chest Society · 2025Article
- Spotlight on Lung Cancer Disparities in India.JCO global oncology · 2025Article
- Management and survival outcomes of patients with lung cancer at a leading radiotherapy centre in Sub-Saharan Africa: a cross-sectional study.Ecancermedicalscience · 2025Article
- Uniqueness of lung cancer in Southeast Asia.The Lancet regional health. Southeast Asia · 2024Review
- Surgery for lung cancer: insight from a state cancer centre in India.Indian journal of thoracic and cardiovascular surgery · 2024Article
- Do we know enough about the effect of low-dose computed tomography screening for lung cancer on mortality to act? An updated systematic review, meta-analysis and network meta-analysis of randomised controlled trials 2017 to 2021.Diagnostic and prognostic research · 2023Article
- Assessment of survival outcomes among lung cancer patients at the National and Referral Hospital in Kenya.Cancer medicine · 2023Article
- Article
- Article
- A clinicoepidemiological profile of lung cancers in India - Results from the National Cancer Registry Programme.The Indian journal of medical research · 2022Article
- Challenges in the Management of Lung Cancer: Real-World Experience from a Tertiary Center in South India.South Asian journal of cancer · 2021Article
- Changes in non-small cell lung cancer diagnosis, molecular testing and prognosis 2011-2016.Journal of thoracic disease · 2018Article
- Prognostic factors for treatment response and survival outcomes after first-line management of Stage 4 non-small cell lung cancer: A real-world Indian perspective.Lung India : official organ of Indian Chest SocietyArticle
- Primary lung cancer with chest wall involvement: Outcomes of a multimodality management approach.Lung India : official organ of Indian Chest SocietyArticle
- Navigating patient journey in early diagnosis of lung cancer in India.Lung India : official organ of Indian Chest SocietyReview
- Clinicopathological characteristics and treatment outcome in small cell lung cancer: A single institutional experience from India.Lung India : official organ of Indian Chest SocietyArticle
- Survival Rates and Predictors of Mortality in Lung Cancer: A Multi-Centre Study in Kerala.Indian journal of community medicine : official publication of Indian Association of Preventive & Social MedicineArticle
- First-line management of metastatic non-small cell lung cancer: An Indian perspective.South Asian journal of cancerReview
- Clinical profile of lung cancer in North India: A 10-year analysis of 1862 patients from a tertiary care center.Lung India : official organ of Indian Chest SocietyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeLung cancer is the most common cause of cancer mortality in the world. There are limited studies on survival outcomes of lung cancer in developing countries such as India. This study analyzed the outcomes of patients with lung cancer who underwent treatment at Cancer Institute (WIA), Chennai, India, between 2006 and 2015 to determine survival outcomes and identify prognostic factors. PATIENTS AND
methodsIn all, 678 patients with lung cancer underwent treatment. Median age was 58 years, and 91% of patients had non-small-cell lung cancer (NSCLC). Testing for epidermal growth factor receptor mutation was performed in 132 of 347 patients and 61 (46%) were positive.
resultsMedian progression-free survival was 6.9 months and overall survival (OS) was 7.6 months for patients with NSCLC. Median progression-free survival was 6 months and OS was 7.2 months for patients with small-cell lung cancer. On multivariable analysis, the factors found to be significantly associated with inferior OS in NSCLC included nonadenocarcinoma histology, performance status more than 2, and stage. In small-cell lung cancer, younger age and earlier stage at presentation showed significantly better survival.
conclusionOur study highlights the challenges faced in treating lung cancer in India. Although median survival in advanced-stage lung cancer is still poor, strategies such as personalized medicine and use of second-line and maintenance chemotherapy may significantly improve the survival in patients with advanced-stage lung cancer in developing countries.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.